conclusion : short-term aerosol administration of human plasma alpha 1-antitrypsin to patients with alpha 1-antitrypsin deficiency is safe and feasible , resulting in a return to normal of anti-neutrophil-elastase defenses in the lower respiratory tract .
C0795657
human
C0221757
alpha 1-antitrypsin deficiency